Mineralys Therapeutics, Inc. Common Stock Net Asset Quality Index
Mineralys Therapeutics, Inc. Common Stock net asset quality index. Mineralys Therapeutics, Inc. Common Stock (MLYS) has a Net Asset Quality Index of 82.5% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $667.85 Million minus total liabilities of $116.94 Million yields net assets of $550.92 Million. A higher index indicates a stronger, lower-leverage balance sheet. See Mineralys Therapeutics, Inc. Common Stoc shareholders equity for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Mineralys Therapeutics, Inc. Common Stock (2020–2025)
Net asset quality index of Mineralys Therapeutics, Inc. Common Stock from 2020 to 2025. This chart shows how Mineralys Therapeutics, Inc. Common Stock's Net Asset Quality Index has evolved across 6 annual periods from 2020 to 2025. As of June 2026, the index stands at 82.5%, representing net assets of $550.92 Million against total assets of $667.85 Million USD. Check how strategically is Mineralys Therapeutics, Inc. Common Stoc's equity deployed to assess the company's strategic physical and investment asset allocation.
Mineralys Therapeutics, Inc. Common Stock Net Asset Quality Index by Year (2020–2025)
Mineralys Therapeutics, Inc. Common Stock net asset quality index by year from 2020 to 2025. The table below presents the year-by-year Net Asset Quality Index for Mineralys Therapeutics, Inc. Common Stock from 2020 to 2025, covering 6 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Mineralys Therapeutics, Inc. Common Stoc market capitalisation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 97.7% | $646.69 Million | $661.81 Million | $15.11 Million | ▲ +4.8 pp |
| 2024 | 92.9% | $191.26 Million | $205.90 Million | $14.65 Million | ▼ -2.9 pp |
| 2023 | 95.8% | $241.15 Million | $251.64 Million | $10.48 Million | ▲ +141.5 pp |
| 2022 | -45.7% | $-52.27 Million | $114.44 Million | $166.71 Million | ▲ +160.4 pp |
| 2021 | -206.1% | $-22.93 Million | $11.12 Million | $34.05 Million | ▲ +36.0 pp |
| 2020 | -242.1% | $-3.60 Million | $1.49 Million | $5.08 Million | — |